tiprankstipranks
Advertisement
Advertisement
Lupin Grants Over 1.56 Million Stock Options Under ESOP 2025
PremiumCompany AnnouncementsLupin Grants Over 1.56 Million Stock Options Under ESOP 2025
2M ago
Lupin Wins U.S. FDA Nod for Interchangeable Lucentis Biosimilar Ranluspec
Premium
Company Announcements
Lupin Wins U.S. FDA Nod for Interchangeable Lucentis Biosimilar Ranluspec
3M ago
Lupin Showcases Promising Phase 1 Data for Novel Oncology Drug LNP8701 at ASCO 2026
Premium
Company Announcements
Lupin Showcases Promising Phase 1 Data for Novel Oncology Drug LNP8701 at ASCO 2026
3M ago
Lupin’s U.S. Arm Settles Humana Antitrust Claim for $30 Million
PremiumCompany AnnouncementsLupin’s U.S. Arm Settles Humana Antitrust Claim for $30 Million
4M ago
Lupin Wins U.S. FDA Nod for Generic Dapagliflozin Tablets
Premium
Company Announcements
Lupin Wins U.S. FDA Nod for Generic Dapagliflozin Tablets
5M ago
Lupin Wins Tentative U.S. FDA Nod for Generic Pitolisant Tablets
Premium
Company Announcements
Lupin Wins Tentative U.S. FDA Nod for Generic Pitolisant Tablets
5M ago
Lupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025
PremiumCompany AnnouncementsLupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025
6M ago
Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases
Premium
Company Announcements
Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases
7M ago
Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
Premium
Company Announcements
Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100